GEVO · available-data snapshot
Gevo, Inc. (GEVO): Available-Data Snapshot
TickerWorth does not publish a DCF fair value for Gevo, Inc. (GEVO); the reason is set out below. What its filings and market data do show is below. The snapshot also sets out its trading multiples against 5 peers. Snapshot as of Oct 19, 2026.
Model by Miraaj Patel · generated from public market data · Updated Oct 19, 2026 · How these pages are made
Why is there no fair value for GEVO?
We do not publish a fair value for Gevo, Inc.. What we can say from its filings and market data is below.
What is GEVO's TickerWorth Score?
Middle of the pack — real strengths and real weaknesses
Compared with Basic Materials companies in US
Its strongest point: trades below our estimate of what it's worth. Its weakest: profitability is weak.
- Value · 74 of 100
Cheaper than 74% of Basic Materials companies in US
- Price vs worth · 100 of 100
- Quality · 18 of 100
More profitable than 18% of Basic Materials companies in US
- Financial health · 57 of 100
Financially stronger than 57% of Basic Materials companies in US
- Growth · 26 of 100
Growing faster than 26% of Basic Materials companies in US
- Momentum · 1 of 100
Outperformed almost none of the Basic Materials companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
- Price
- $1.16
- Market cap
- $285,
558, 848 - 52-week high
- $2.97
- 52-week low
- $1.15
- Currency
- USD
- Exchange
- NasdaqCM
Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.
What we can say
We don't publish a discounted-cash-flow fair value for Gevo, Inc. (GEVO) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.
Read the full reasoning
On the numbers we do have, GEVO trades at a recent price of $1.16, a market capitalisation of about $285,558,848, sitting 0% of the way up its 52-week range ($1.15–$2.97), on the NasdaqCM.
The standard alternative to a DCF is relative valuation — comparing GEVO's trading multiples against a sector benchmark. Here that gives Fwd P/E of 19.2× (in line with the peer median of 20.8×); P/B of 1.0× (cheaper than the peer median of 5.0×); P/S of 1.6× (cheaper than the peer median of 4.8×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. GEVO shows a price-to-book (P/B) of 1.01 and book value of $1.14 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.
Finally, a price-based read — explicitly not a valuation. GEVO is in a down-trend (price below both its 50- and 200-day averages), trading -61.1% from its 52-week high. Over the past year the stock is -55.2%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
GEVO vs peers
Sector benchmark (bellwethers, not direct competitors).
| Multiple | GEVO | Peer median | Read |
|---|---|---|---|
| Fwd P/E | 19.2× | 20.8× | in line with |
| P/B | 1.0× | 5.0× | cheaper than |
| P/S | 1.6× | 4.8× | cheaper than |
What does Gevo, Inc. do?
What does it do?
Gevo, Inc. operates as a carbon abatement company. It operates in the Specialty Chemicals industry (Basic Materials sector), headquartered in United States. The company employs roughly 151 people.
How does it make money?
The business turns $161M in annual revenue into profit. Out of every $100 of sales, about $0 is left as operating profit (operating margin of -76.8%), after a 45% gross margin on the products/services it sells. After all costs, taxes and interest, -119.9% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks mixed: carries modest debt (0.6× equity), comfortably covers its short-term bills (2.7× current ratio), and is currently lossmaking.
Who at GEVO filed insider trades?
| Date | Insider | Relationship | What happened | Value | Filing |
|---|---|---|---|---|---|
| Bowron Kimberly T | Chief of Staff | Open-market sale | $2,087.79 | Form 4 for Bowron Kimberly T (opens sec.gov in a new tab) | |
| Bloom Paul D | Director, CEO | Open-market sale | $2,588.79 | Form 4 for Bloom Paul D (opens sec.gov in a new tab) | |
| Gruber Patrick R. | Director | Open-market sale | $5,671.43 | Form 4 for Gruber Patrick R. (opens sec.gov in a new tab) | |
| Kettner David Michael | Chief Legal & Emrg Biz Officer | Open-market buy | $19,368.75 | Form 4 for Kettner David Michael (opens sec.gov in a new tab) | |
| Barber James J | Director | Open-market buy | $77,000.00 | Form 4 for Barber James J (opens sec.gov in a new tab) | |
| Werpy Todd Allen | Director | Grant / award | — | Form 4 for Werpy Todd Allen (opens sec.gov in a new tab) |
A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans
Companies we do put a number on
Not investment advice. TickerWorth Score is a model output.
A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.